437 related articles for article (PubMed ID: 10994531)
1. Escherichia coli Shiga toxin.
Nakao H; Takeda T
J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
[TBL] [Abstract][Full Text] [Related]
2. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
Mainil J
Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.
Eisenhauer PB; Jacewicz MS; Conn KJ; Koul O; Wells JM; Fine RE; Newburg DS
Microb Pathog; 2004 Apr; 36(4):189-96. PubMed ID: 15001224
[TBL] [Abstract][Full Text] [Related]
4. [Cytotoxic effect of Shiga toxin type 2 and its B subunit on human renal tubular epithelial cell cultures].
Creydt VP; Nuñez P; Zotta E; Ibarra C
Medicina (B Aires); 2005; 65(2):147-50. PubMed ID: 16075810
[TBL] [Abstract][Full Text] [Related]
5. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome.
Karch H; Friedrich AW; Gerber A; Zimmerhackl LB; Schmidt MA; Bielaszewska M
Semin Thromb Hemost; 2006 Mar; 32(2):105-12. PubMed ID: 16575685
[TBL] [Abstract][Full Text] [Related]
6. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.
Donohue-Rolfe A; Kondova I; Oswald S; Hutto D; Tzipori S
J Infect Dis; 2000 May; 181(5):1825-9. PubMed ID: 10823794
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells.
Harrison LM; Cherla RP; van den Hoogen C; van Haaften WC; Lee SY; Tesh VL
Microb Pathog; 2005; 38(2-3):63-76. PubMed ID: 15748808
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells.
Brandelli JR; Griener TP; Laing A; Mulvey G; Armstrong GD
Toxins (Basel); 2015 Oct; 7(10):4054-66. PubMed ID: 26473922
[TBL] [Abstract][Full Text] [Related]
9. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
Karch H
Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
[TBL] [Abstract][Full Text] [Related]
10. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
[TBL] [Abstract][Full Text] [Related]
11. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.
Brooks JT; Sowers EG; Wells JG; Greene KD; Griffin PM; Hoekstra RM; Strockbine NA
J Infect Dis; 2005 Oct; 192(8):1422-9. PubMed ID: 16170761
[TBL] [Abstract][Full Text] [Related]
12. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
[TBL] [Abstract][Full Text] [Related]
13. Shiga toxin-producing Escherichia coli: an overview.
Gyles CL
J Anim Sci; 2007 Mar; 85(13 Suppl):E45-62. PubMed ID: 17085726
[TBL] [Abstract][Full Text] [Related]
14. Racing, ornamental and city pigeons carry shiga toxin producing Escherichia coli (STEC) with different Shiga toxin subtypes, urging further analysis of their epidemiological role in the spread of STEC.
Grossmann K; Weniger B; Baljer G; Brenig B; Wieler LH
Berl Munch Tierarztl Wochenschr; 2005; 118(11-12):456-63. PubMed ID: 16318269
[TBL] [Abstract][Full Text] [Related]
15. Shiga toxin-producing Escherichia coli and their bacteriophages as a model for the analysis of virulence and stress response of a food-borne pathogen.
Creuzburg K; Schmidt H
Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):288-95. PubMed ID: 17715821
[TBL] [Abstract][Full Text] [Related]
16. Shiga toxin-producing Escherichia coli infection.
Thorpe CM
Clin Infect Dis; 2004 May; 38(9):1298-303. PubMed ID: 15127344
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cytokines on the expression of Shiga toxin toxicity].
Nakane A; Sasaki S
Nihon Rinsho; 2002 Jun; 60(6):1089-94. PubMed ID: 12078078
[TBL] [Abstract][Full Text] [Related]
18. Conserved Stx2 phages from Escherichia coli O103:H25 isolated from patients suffering from hemolytic uremic syndrome.
Sekse C; Muniesa M; Wasteson Y
Foodborne Pathog Dis; 2008 Dec; 5(6):801-10. PubMed ID: 19014273
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
20. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes.
Geelen JM; van der Velden TJ; Te Loo DM; Boerman OC; van den Heuvel LP; Monnens LA
Nephrol Dial Transplant; 2007 Mar; 22(3):749-55. PubMed ID: 17127697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
